Pradhan Shashwati, Gomez-Lobo Veronica
Division of Pediatric and Adolescent Gynecology, Washington Hospital Center, Children's National Medical Center, Georgetown University, Washington, DC.
Division of Pediatric and Adolescent Gynecology, Washington Hospital Center, Children's National Medical Center, Georgetown University, Washington, DC.
J Pediatr Adolesc Gynecol. 2019 Sep;32(5S):S23-S29. doi: 10.1016/j.jpag.2019.04.007. Epub 2019 Apr 11.
Menstrual suppression (the use of hormonal contraceptive methods to eliminate or significantly decrease the frequency of menstrual cycles) is frequently used in the adolescent population for the management of menstrual symptoms such as heavy or painful periods, premenstrual syndrome, menstrual migraines, or even for patient preference. However, in cases of menstrual suppression in special populations additional risks and benefits need to be considered. The purpose of this article is to review the options and medical considerations for menstrual suppression in patients undergoing chemotherapy who might be at risk of abnormal uterine bleeding, those with intellectual or physical disability, and transgender and gender nonbinary individuals.
月经抑制(使用激素避孕方法来消除或显著减少月经周期的频率)在青少年人群中经常被用于管理月经症状,如月经量过多或疼痛、经前综合征、月经性偏头痛,甚至是出于患者的个人偏好。然而,在特殊人群进行月经抑制的情况下,需要考虑额外的风险和益处。本文的目的是回顾在接受化疗、可能有异常子宫出血风险的患者,以及有智力或身体残疾的患者、跨性别者和性别非二元者中进行月经抑制的选择和医学考量。